Groombridge Wu Baughman Stone LLP

General

Please sign up or log in to access the advanced features of
Ex Parte Professional.

or Log in

Cases47

Challenger50%

Patent Owner50%

NPE50%

Practice Areas

BiotechTransport., E-Comm.Chemical

Top Attorneys

Patrick J. CoyneNeal S. CohenPeter Kinsella

Elite Ratings

DCTPTABCAFC

Ratings

Please sign up or log in to access the advanced features of
Ex Parte Professional.

or Log in

Experience

Grade

Trend

DCT

PTAB

CAFC

Analytics

Lawyers

Cases

Ratings Trends

Practice Areas

Recent Dockets

Entered	Case	Description
09/17/24	Alnylam Pharmaceuticals Inc v. Pfizer Inc 1:22-CV-00336 ( D. DE )	MOTION for Exemption From the May 17, 2024, Standing Order Regarding Personal Electronic Devices - filed by BioNTech Manufacturing GmbH, BioNTech SE. (Raucci, Anthony) (Entered: 09/17/2024)
09/17/24	Alnylam Pharmaceuticals Inc v. Pfizer Inc 1:22-CV-00336 ( D. DE )	[SEALED] Letter to The Honorable Colm F. Connolly from Ethan H. Townsend, Esq. regarding Defendants' Motion to Strike the Opening Expert Report of Dr. Karl Scheidt, Ph.D. - re [255] Letter. (Attachments: # [1] Exhibit 1, # [2] Exhibit 2, # [3] Certificate of Service)(Townsend, Ethan) (Entered: 09/17/2024)
09/17/24	Alnylam Pharmaceuticals Inc v. Pfizer Inc 1:22-CV-00336 ( D. DE )	[SEALED] Letter to The Honorable Colm F. Connolly from Jeremy A. Tigan regarding Defendants' Response - re [253] MOTION to Strike [252] Letter, [Plaintiff Alnylam Pharmaceuticals, Inc.'s Motion to Strike Portions of the Opening Expert Report of Kathryn Whitehead, Ph.D.]. (Attachments: # [1] Ex. A)(Tigan, Jeremy) (Entered: 09/17/2024)
09/13/24	10X Genomics Inc v. Parse Biosciences Inc 1:22-CV-01117 ( D. DE )	[SEALED] DECLARATION re [260] Opening Brief in Support, of Derek C. Walter by Parse Biosciences, Inc.. (Attachments: # [1] Exhibit A, # [2] Exhibit B, # [3] Exhibit C, # [4] Exhibit D, # [5] Exhibit E, # [6] Exhibit F, # [7] Exhibit G, # [8] Exhibit H, # [9] Exhibit I, # [10] Exhibit J, # [11] Exhibit K, # [12] Exhibit L, # [13] Exhibit M, # [14] Exhibit N, # [15] Exhibit O, # [16] Exhibit P, # [17] Exhibit Q, # [18] Exhibit R, # [19] Exhibit S, # [20] Exhibit T, # [21] Exhibit U, # [22] Exhibit V, # [23] Exhibit W, # [24] Exhibit X, # [25] Exhibit Y, # [26] Exhibit Z, # [27] Exhibit AA)(Farnan, Michael) (Entered: 09/13/2024) [SEALED] DECLARATION re [260] Opening Brief in Support, of Derek C. Walter by Parse Biosciences, Inc.. (Attachments: # [1] Exhibit A, # [2] Exhibit B, # [3] Exhibit C, # [4] Exhibit D, # [5] Exhibit E, # [6] Exhibit F, # [7] Exhibit G, # [8] Exhibit H, # [9] Exhibit I, # [10] Exhibit J, # [11] Exhibit K, # [12] Exhibit L, # [13] Exhibit M, # [14] Exhibit N, # [15] Exhibit O, # [16] Exhibit P, # [17] Exhibit Q, # [18] Exhibit R, # [19] Exhibit S, # [20] Exhibit T, # [21] Exhibit U, # [22] Exhibit V, # [23] Exhibit W, # [24] Exhibit X, # [25] Exhibit Y, # [26] Exhibit Z, # [27] Exhibit AA)(Farnan, Michael) (Entered: 09/13/2024)
09/13/24	10X Genomics Inc v. Parse Biosciences Inc 1:22-CV-01117 ( D. DE )	[SEALED] STATEMENT re [259] MOTION for Summary Judgment MOTION to Preclude Expert Testimony Statement of Undisputed Material Facts in Support of its Motions for Summary Judgment by Parse Biosciences, Inc.. (Farnan, Michael) (Entered: 09/13/2024)
09/13/24	10X Genomics Inc v. Parse Biosciences Inc 1:22-CV-01117 ( D. DE )	[SEALED] OPENING BRIEF in Support re [259] MOTION for Summary Judgment MOTION to Preclude Expert Testimony filed by Parse Biosciences, Inc..Answering Brief/Response due date per Local Rules is 9/27/2024. (Farnan, Michael) (Entered: 09/13/2024)
09/13/24	10X Genomics Inc v. Parse Biosciences Inc 1:22-CV-01117 ( D. DE )	MOTION for Summary Judgment , MOTION to Preclude Expert Testimony - filed by Parse Biosciences, Inc.. (Farnan, Michael) (Entered: 09/13/2024)
09/12/24	Biontech Se v. Curevac Se 2:23-CV-00222 ( E.D. VA )	Request for Hearing by CureVac SE, CureVac Manufacturing GmbH, CureVac SE re [390] MOTION to Strike Counterclaim Defendants' "Supplemental Identification of Seven Prior Art-Based Invalidity Arguments Per Asserted Claim" (Joint Request for Oral Argument) (Erbach, John) (Entered: 09/12/2024)
09/12/24	Amicus Therapeutics US LLC v. Teva Pharmaceuticals USA Inc 1:22-CV-01461 ( D. DE )	NOTICE OF SERVICE of (1) Defendants, Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.s Responses and Objections to Plaintiffs First Set of Requests for Admission (Nos. 1-11); (2) Defendants, Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.s Responses and Objections to Plaintiffs Fourth Set of Interrogatories (Nos. 15-17); and (3) Defendants, Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.s Responses and Objections to Plaintiffs Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Myer, R.) (Entered: 09/12/2024) NOTICE OF SERVICE of (1) Defendants, Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.s Responses and Objections to Plaintiffs First Set of Requests for Admission (Nos. 1-11); (2) Defendants, Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.s Responses and Objections to Plaintiffs Fourth Set of Interrogatories (Nos. 15-17); and (3) Defendants, Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.s Responses and Objections to Plaintiffs Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Myer, R.) (Entered: 09/12/2024)
09/12/24	Ossifi Mab LLC v. Amgen Inc 1:23-CV-10861 ( D. MA )	Joint MOTION to Amend by OssiFi-Mab LLC.(Reddy, Srikanth) (Entered: 09/12/2024)